Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 203.9 EUR 0.39% Market Closed
Market Cap: 19.8B EUR
Have any thoughts about
Sartorius Stedim Biotech SA?
Write Note

Intrinsic Value

The intrinsic value of one DIM stock under the Base Case scenario is 177.56 EUR. Compared to the current market price of 203.9 EUR, Sartorius Stedim Biotech SA is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DIM Intrinsic Value
177.56 EUR
Overvaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sartorius Stedim Biotech SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
DIM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DIM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Sartorius Stedim Biotech SA
PAR:DIM
FR
Life Sciences Tools & Services
Market Cap
19.8B EUR
IPO
Oct 20, 1994
FR
Life Sciences Tools & Services
Market Cap
19.8B EUR
IPO
Oct 20, 1994
Price
€
€
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Sartorius Stedim Biotech SA

Provide an overview of the primary business activities
of Sartorius Stedim Biotech SA.

What unique competitive advantages
does Sartorius Stedim Biotech SA hold over its rivals?

What risks and challenges
does Sartorius Stedim Biotech SA face in the near future?

Has there been any significant insider trading activity
in Sartorius Stedim Biotech SA recently?

Summarize the latest earnings call
of Sartorius Stedim Biotech SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sartorius Stedim Biotech SA.

Provide P/S
for Sartorius Stedim Biotech SA.

Provide P/E
for Sartorius Stedim Biotech SA.

Provide P/OCF
for Sartorius Stedim Biotech SA.

Provide P/FCFE
for Sartorius Stedim Biotech SA.

Provide P/B
for Sartorius Stedim Biotech SA.

Provide EV/S
for Sartorius Stedim Biotech SA.

Provide EV/GP
for Sartorius Stedim Biotech SA.

Provide EV/EBITDA
for Sartorius Stedim Biotech SA.

Provide EV/EBIT
for Sartorius Stedim Biotech SA.

Provide EV/OCF
for Sartorius Stedim Biotech SA.

Provide EV/FCFF
for Sartorius Stedim Biotech SA.

Provide EV/IC
for Sartorius Stedim Biotech SA.

Show me price targets
for Sartorius Stedim Biotech SA made by professional analysts.

What are the Revenue projections
for Sartorius Stedim Biotech SA?

How accurate were the past Revenue estimates
for Sartorius Stedim Biotech SA?

What are the Net Income projections
for Sartorius Stedim Biotech SA?

How accurate were the past Net Income estimates
for Sartorius Stedim Biotech SA?

What are the EPS projections
for Sartorius Stedim Biotech SA?

How accurate were the past EPS estimates
for Sartorius Stedim Biotech SA?

What are the EBIT projections
for Sartorius Stedim Biotech SA?

How accurate were the past EBIT estimates
for Sartorius Stedim Biotech SA?

Compare the revenue forecasts
for Sartorius Stedim Biotech SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sartorius Stedim Biotech SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sartorius Stedim Biotech SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sartorius Stedim Biotech SA compared to its peers.

Compare the P/E ratios
of Sartorius Stedim Biotech SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Sartorius Stedim Biotech SA with its peers.

Analyze the financial leverage
of Sartorius Stedim Biotech SA compared to its main competitors.

Show all profitability ratios
for Sartorius Stedim Biotech SA.

Provide ROE
for Sartorius Stedim Biotech SA.

Provide ROA
for Sartorius Stedim Biotech SA.

Provide ROIC
for Sartorius Stedim Biotech SA.

Provide ROCE
for Sartorius Stedim Biotech SA.

Provide Gross Margin
for Sartorius Stedim Biotech SA.

Provide Operating Margin
for Sartorius Stedim Biotech SA.

Provide Net Margin
for Sartorius Stedim Biotech SA.

Provide FCF Margin
for Sartorius Stedim Biotech SA.

Show all solvency ratios
for Sartorius Stedim Biotech SA.

Provide D/E Ratio
for Sartorius Stedim Biotech SA.

Provide D/A Ratio
for Sartorius Stedim Biotech SA.

Provide Interest Coverage Ratio
for Sartorius Stedim Biotech SA.

Provide Altman Z-Score Ratio
for Sartorius Stedim Biotech SA.

Provide Quick Ratio
for Sartorius Stedim Biotech SA.

Provide Current Ratio
for Sartorius Stedim Biotech SA.

Provide Cash Ratio
for Sartorius Stedim Biotech SA.

What is the historical Revenue growth
over the last 5 years for Sartorius Stedim Biotech SA?

What is the historical Net Income growth
over the last 5 years for Sartorius Stedim Biotech SA?

What is the current Free Cash Flow
of Sartorius Stedim Biotech SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sartorius Stedim Biotech SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sartorius Stedim Biotech SA

Current Assets 1.8B
Cash & Short-Term Investments 727m
Receivables 296.4m
Other Current Assets 756.6m
Non-Current Assets 6.5B
Long-Term Investments 23.7m
PP&E 1.9B
Intangibles 4.5B
Other Non-Current Assets 72.1m
Current Liabilities 964.7m
Accounts Payable 317m
Accrued Liabilities 84.8m
Other Current Liabilities 562.9m
Non-Current Liabilities 3.4B
Long-Term Debt 2.8B
Other Non-Current Liabilities 524.2m
Efficiency

Free Cash Flow Analysis
Sartorius Stedim Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sartorius Stedim Biotech SA

Revenue
2.9B EUR
Cost of Revenue
-1.6B EUR
Gross Profit
1.3B EUR
Operating Expenses
-852.8m EUR
Operating Income
401.5m EUR
Other Expenses
-197.2m EUR
Net Income
204.3m EUR
Fundamental Scores

DIM Profitability Score
Profitability Due Diligence

Sartorius Stedim Biotech SA's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
52/100
Profitability
Score

Sartorius Stedim Biotech SA's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

DIM Solvency Score
Solvency Due Diligence

Sartorius Stedim Biotech SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
47/100
Solvency
Score

Sartorius Stedim Biotech SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DIM Price Targets Summary
Sartorius Stedim Biotech SA

Wall Street analysts forecast DIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DIM is 248.41 EUR with a low forecast of 202 EUR and a high forecast of 304.5 EUR.

Lowest
Price Target
202 EUR
1% Downside
Average
Price Target
248.41 EUR
22% Upside
Highest
Price Target
304.5 EUR
49% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DIM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DIM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DIM stock?

The intrinsic value of one DIM stock under the Base Case scenario is 177.56 EUR.

Is DIM stock undervalued or overvalued?

Compared to the current market price of 203.9 EUR, Sartorius Stedim Biotech SA is Overvalued by 13%.

Back to Top